The arrival of Retatrutide ZPHC, at a concentration of 120mg, is creating considerable interest within the healthcare community. This groundbreaking dual GIP and GLP-1 receptor medication appears to offer significant improvements in fat shedding compared to existing therapies. Preliminary researc